Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia

Testing for MYD88 mutations using AS-PCR or ddPCR in unsorted samples is viable for routine clinical practice. Under BTKi treatment, MYD88 and CXCR4 mutations hold greater prognostic importance than IPSSWM staging in WM.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2024-10-07
DOI
https://doi.org/10.1158/1078-0432.ccr-23-3939
Citations
8
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
3.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia

Wenjie Xiong, Zhijian Xiao, Yuxi Li, Dehui Zou et al.
8 citations
Clinical Cancer Research
Chronic Lymphocytic Leukemia Research
3.50
article

Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia

Wenjie Xiong, Zhijian Xiao, Yuxi Li, Dehui Zou, Lugui Qiu, Gang An, Shuhua Yi, Hao Sun, Yao Yao, Mu Hao, Tingyu Wang, Yuting Yan, Haoxu Wang, Weiwei Sui, Jianxiang Wang, Yan Xu, Wei Liu, Jun Wang, Ying Yu, Zhen Yu, Yanshan Huang, Rui Lv, Yujiao Jia, Wang Qi, Wenyang Huang
article en
8 citations

Abstract

Testing for MYD88 mutations using AS-PCR or ddPCR in unsorted samples is viable for routine clinical practice. Under BTKi treatment, MYD88 and CXCR4 mutations hold greater prognostic importance than IPSSWM staging in WM.

Clinical Cancer ResearchVol. 30(23)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Institute of Hematology & Blood Diseases Hospital (CN)
National Natural Science Foundation of China, Chinese Academy of Medical Sciences, Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Good health and well-being
Openalex Percentile: Top 7%
Chronic Lymphocytic Leukemia Research
3.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.